132 related articles for article (PubMed ID: 12431054)
21. Pharmacology of nociceptin and its receptor: a novel therapeutic target.
Calo' G; Guerrini R; Rizzi A; Salvadori S; Regoli D
Br J Pharmacol; 2000 Apr; 129(7):1261-83. PubMed ID: 10742280
[TBL] [Abstract][Full Text] [Related]
22. The nociceptin pharmacophore site for opioid receptor binding derived from the NMR structure and bioactivity relationships.
Orsini MJ; Nesmelova I; Young HC; Hargittai B; Beavers MP; Liu J; Connolly PJ; Middleton SA; Mayo KH
J Biol Chem; 2005 Mar; 280(9):8134-42. PubMed ID: 15596448
[TBL] [Abstract][Full Text] [Related]
23. Nonpeptide/peptide chimeric ligands for the nociceptin/orphanin FQ receptor: design, synthesis and in vitro pharmacological activity.
Guerrini R; Carra' G; Calo' G; Trapella C; Marzola E; Rizzi D; Regoli D; Salvadori S
J Pept Res; 2004 Jun; 63(6):477-84. PubMed ID: 15175020
[TBL] [Abstract][Full Text] [Related]
24. In vitro characterization of Ac-RYYRWK-NH(2), Ac-RYYRIK-NH(2) and [Phe1Psi(CH(2)-NH)Gly2] nociceptin(1-13)NH(2) at rat native and recombinant ORL(1) receptors.
Mason SL; Ho M; Nicholson J; McKnight AT
Neuropeptides; 2001; 35(5-6):244-56. PubMed ID: 12030809
[TBL] [Abstract][Full Text] [Related]
25. Sensitivity of opioid receptor-like receptor ORL1 for chemical modification on nociceptin, a naturally occurring nociceptive peptide.
Shimohigashi Y; Hatano R; Fujita T; Nakashima R; Nose T; Sujaku T; Saigo A; Shinjo K; Nagahisa A
J Biol Chem; 1996 Sep; 271(39):23642-5. PubMed ID: 8798582
[TBL] [Abstract][Full Text] [Related]
26. Nociceptin (ORL-1) and mu-opioid receptors mediate mitogen-activated protein kinase activation in CHO cells through a Gi-coupled signaling pathway: evidence for distinct mechanisms of agonist-mediated desensitization.
Hawes BE; Fried S; Yao X; Weig B; Graziano MP
J Neurochem; 1998 Sep; 71(3):1024-33. PubMed ID: 9721727
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological characterization of the nociceptin receptor which mediates reduction of alcohol drinking in rats.
Ciccocioppo R; Polidori C; Antonelli L; Salvadori S; Guerrini R; Massi M
Peptides; 2002 Jan; 23(1):117-25. PubMed ID: 11814626
[TBL] [Abstract][Full Text] [Related]
28. Evidence that [Phe1 psi(CH2-NH)Gly2]nociceptin-(1-13)-NH2, a peripheral ORL-1 receptor antagonist, acts as an agonist in the rat spinal cord.
Carpenter KJ; Dickenson AH
Br J Pharmacol; 1998 Nov; 125(5):949-51. PubMed ID: 9846631
[TBL] [Abstract][Full Text] [Related]
29. Biochemical and pharmacological investigation of novel nociceptin/OFQ analogues and N/OFQ-RYYRIK hybrid peptides.
Erdei AI; Borbély A; Magyar A; Szűcs E; Ötvös F; Gombos D; Al-Khrasani M; Stefanucci A; Dimmito MP; Luisi G; Mollica A; Benyhe S
Peptides; 2019 Feb; 112():106-113. PubMed ID: 30513351
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, biological evaluation and structural characterization of novel glycopeptide analogues of nociceptin N/OFQ.
Arsequell G; Rosa M; Mayato C; Dorta RL; Gonzalez-Nunez V; Barreto-Valer K; Marcelo F; Calle LP; Vázquez JT; Rodríguez RE; Jiménez-Barbero J; Valencia G
Org Biomol Chem; 2011 Sep; 9(17):6133-42. PubMed ID: 21773621
[TBL] [Abstract][Full Text] [Related]
31. UFP-112 a potent and long-lasting agonist selective for the Nociceptin/Orphanin FQ receptor.
Calo' G; Rizzi A; Cifani C; Micioni Di Bonaventura MV; Regoli D; Massi M; Salvadori S; Lambert DG; Guerrini R
CNS Neurosci Ther; 2011 Jun; 17(3):178-98. PubMed ID: 20497197
[TBL] [Abstract][Full Text] [Related]
32. Antagonistic effects of [Nphe1]nociceptin(1-13)NH2 on nociceptin receptor mediated inhibition of cAMP formation in Chinese hamster ovary cells stably expressing the recombinant human nociceptin receptor.
Hashimoto Y; Caló G; Guerrini R; Smith G; Lambert DG
Neurosci Lett; 2000 Jan; 278(1-2):109-12. PubMed ID: 10643813
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)amide analogues. 1. In vitro studies.
Bigoni R; Rizzi D; Rizzi A; Camarda V; Guerrini R; Lambert DG; Hashiba E; Berger H; Salvadori S; Regoli D; Calo' G
Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun; 365(6):442-9. PubMed ID: 12070757
[TBL] [Abstract][Full Text] [Related]
34. Parathyroid hormone (PTH)-(1-14) and -(1-11) analogs conformationally constrained by alpha-aminoisobutyric acid mediate full agonist responses via the juxtamembrane region of the PTH-1 receptor.
Shimizu N; Guo J; Gardella TJ
J Biol Chem; 2001 Dec; 276(52):49003-12. PubMed ID: 11604398
[TBL] [Abstract][Full Text] [Related]
35. Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist.
Calo' G; Guerrini R; Bigoni R; Rizzi A; Bianchi C; Regoli D; Salvadori S
J Med Chem; 1998 Aug; 41(18):3360-6. PubMed ID: 9719588
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological studies of nociceptin derivatives containing the DTPA chelating group for further labeling with therapeutic radionuclides.
Ligeti M; Gündüz O; Magyar A; Kató E; Rónai AZ; Vita C; Varga I; Hudecz F; Tóth G; Borsodi A; Benyhe S
Peptides; 2005 Jul; 26(7):1159-66. PubMed ID: 15949634
[TBL] [Abstract][Full Text] [Related]
37. A Dynamic Picture of the Early Events in Nociceptin Binding to the NOP Receptor by Metadynamics.
Della Longa S; Arcovito A
Biophys J; 2016 Sep; 111(6):1203-1213. PubMed ID: 27653479
[TBL] [Abstract][Full Text] [Related]
38. Structure-activity studies on different modifications of nociceptin/orphanin FQ: identification of highly potent agonists and antagonists of its receptor.
Chang M; Peng YL; Dong SL; Han RW; Li W; Yang DJ; Chen Q; Wang R
Regul Pept; 2005 Sep; 130(3):116-22. PubMed ID: 15935490
[TBL] [Abstract][Full Text] [Related]
39. Molecular modelling of the ORL1 receptor and its complex with nociceptin.
Topham CM; Moulédous L; Poda G; Maigret B; Meunier JC
Protein Eng; 1998 Dec; 11(12):1163-79. PubMed ID: 9930666
[TBL] [Abstract][Full Text] [Related]
40. Nociceptin augments K(+) currents in hippocampal CA1 neurons by both ORL-1 and opiate receptor mechanisms.
Madamba SG; Schweitzer P; Siggins GR
J Neurophysiol; 1999 Oct; 82(4):1776-85. PubMed ID: 10515967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
